Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Muriel Paul"'
Autor:
C. Forasassi, Agathe Raynaud-Simon, Luc Cynober, Ester Guery, C. Faure, Christian Aussel, Philippe Le Corvoisier, Alain Astier, Nathalie Neveux, Stéphane Herbaud, O. Bouillanne, Yves Boirie, Muriel Paul, J.-C. Melchior, Valérie Nivet-Antoine, Didier Chevenne, Stéphane Walrand, Florence Canoui-Poitrine
Publikováno v:
Clinical Nutrition
Clinical Nutrition, Elsevier, 2019, 38 (2), pp.564-574. ⟨10.1016/j.clnu.2018.02.017⟩
Clinical Nutrition, 2019, 38 (2), pp.564-574. ⟨10.1016/j.clnu.2018.02.017⟩
Clinical Nutrition, Elsevier, 2019, 38 (2), pp.564-574. ⟨10.1016/j.clnu.2018.02.017⟩
Clinical Nutrition, 2019, 38 (2), pp.564-574. ⟨10.1016/j.clnu.2018.02.017⟩
BACKGROUND: Citrulline (CIT), is not extracted by the splanchnic area, can stimulate muscle protein synthesis and could potentially find clinical applications in conditions involving low amino acid (AA) intake, such as in malnourished older subjects.
Publikováno v:
Annales Pharmaceutiques Françaises. 71:358-363
Currently, severe erectile dysfunction can be treated by intracavernous injections of solutions containing three active ingredients: prostaglandin E1 (PGE1), papaverine and urapidil. Very few data exist on this mixture where phentolamine has been rep
Publikováno v:
International Journal for Parasitology. 30:777-783
The use of drug delivery systems may reduce the toxicity and improve the activity of anti-leishmanial compounds. The activity of atovaquone (ATV)-loaded liposomes was compared by determination of median eAective doses (ED25 and ED50), with that of fr
Publikováno v:
International Journal for Parasitology. 27:1361-1367
The use of drug delivery systems may reduce the toxicity and improve the activity of antileishmanial compounds. In view of such a strategy, we loaded the antileishmanial agent pentamidine on polymethacrylate nanoparticles. The activity of pentamidine
Autor:
Muriel Paul, Stéphane Culine, Isabelle Baumgaertner, Linda Bouaita, Muriel Verlinde-Carvalho, Julien Grenier, C. Delbaldo, Iradj Sobhani, Elias Assaf, Claude Tayar, Zineb Sellam, Damien Pouessel
Publikováno v:
Oncology. 80(5-6)
Background: To evaluate the efficacy and toxicity of irinotecan and oxaliplatin plus 5-fluorouracil (FU) and leucovorin (FOLFIRINOX) as second-line therapy in metastatic pancreatic adenocarcinoma (MPA). Patients and Methods: We retrospectively analyz
Autor:
Alain Astier, Rene Houin, Rémy Durand, Francine Pratlong, Muriel Paul, M. Deniau, D Rivollet, Marie-Laure Dubreuil-Lemaire
Publikováno v:
Antimicrobial Agents and Chemotherapy. 42:2141-2143
Amphotericin B (AmB) has been used as a second-line treatment of visceral leishmaniasis, particularly in human immunodeficiency virus-positive patients. AmB median effective doses (ED 50 s) were determined on an isolate obtained before any treatment
Publikováno v:
Annals of Tropical Medicine and Parasitology
Annals of Tropical Medicine and Parasitology, Maney Publishing, 2003, 97 (3), pp.259-268. ⟨10.1179/000349803235001840⟩
Annals of Tropical Medicine and Parasitology, Maney Publishing, 2003, 97 (3), pp.259-268. ⟨10.1179/000349803235001840⟩
International audience; The activities of free atovaquone (ATV) and of poly(D,L-lactide) nanocapsules loaded with the drug, in the treatment of mice with visceral leishmaniasis caused by Leishmania infantum, were compared. Each mouse was infected int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14956073f1af0d0952d5c257024845a5
https://hal.inrae.fr/hal-02682381
https://hal.inrae.fr/hal-02682381
The efficacy of a new liposomal formulation of amphotericin B was compared to that of amphotericin B deoxycholate (Fungizone) in a murine model of visceral leishmaniasis induced by Leishmania infantum. Median effective doses (ED50) were determined wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2907e00ba3acb145232b4c3dba0d45b0
https://europepmc.org/articles/PMC163994/
https://europepmc.org/articles/PMC163994/
Autor:
Martin Soubrier, Fernando Kemta Lekpa, Rémy Bruckert, Valérie Farrenq, Muriel Paul, Philippe Goupille, Eric Toussirot, Cécile Poulain, Daniel Wendling, P. Claudepierre, Thao Pham, Philippe Gaudin, J M Berthelot, Michel De Bandt, Jérémie Sellam
Publikováno v:
Arthritis Research & Therapy
Introduction The aim of this study was to evaluate, under real-life conditions, the safety and efficacy of tocilizumab in patients having failed anti-TNFα therapy for spondyloarthritis. Methods French rheumatologists and internal-medicine practition